Diabetes Mellitus and Alzheimer’s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models

Diabetes mellitus is considered as a risk factor of Alzheimer’s disease (AD), the front runner of neurodegenerative disorders. Streptozotocin (STZ) is a toxin for pancreatic β-cell, which can construct a model of insulin deficient diabetes through intraperitoneal or intravenous injection. A model ge...

Full description

Bibliographic Details
Main Authors: Jin-Jing Jia, Xian-Si Zeng, Xin-Qiang Song, Peng-Peng Zhang, Lei Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00834/full
_version_ 1818111304608514048
author Jin-Jing Jia
Jin-Jing Jia
Jin-Jing Jia
Xian-Si Zeng
Xian-Si Zeng
Xian-Si Zeng
Xin-Qiang Song
Peng-Peng Zhang
Lei Chen
author_facet Jin-Jing Jia
Jin-Jing Jia
Jin-Jing Jia
Xian-Si Zeng
Xian-Si Zeng
Xian-Si Zeng
Xin-Qiang Song
Peng-Peng Zhang
Lei Chen
author_sort Jin-Jing Jia
collection DOAJ
description Diabetes mellitus is considered as a risk factor of Alzheimer’s disease (AD), the front runner of neurodegenerative disorders. Streptozotocin (STZ) is a toxin for pancreatic β-cell, which can construct a model of insulin deficient diabetes through intraperitoneal or intravenous injection. A model generated by intracerebroventricular STZ (icv-STZ) also shows numerous aspects of sporadic AD. The protective roles of tea polyphenols epigallocatechin-3-gallate (EGCG) on both two diseases were researched by some scientists. This review highlights the link between diabetes and AD and recent studies on STZ injection-induced models, and also discusses the protection of EGCG to clarify its treatment in STZ-induced diabetes and AD.
first_indexed 2024-12-11T03:00:55Z
format Article
id doaj.art-b34e3e59039d43b682cd63b5f748cd2f
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-11T03:00:55Z
publishDate 2017-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-b34e3e59039d43b682cd63b5f748cd2f2022-12-22T01:23:03ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122017-11-01810.3389/fphar.2017.00834319273Diabetes Mellitus and Alzheimer’s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced ModelsJin-Jing Jia0Jin-Jing Jia1Jin-Jing Jia2Xian-Si Zeng3Xian-Si Zeng4Xian-Si Zeng5Xin-Qiang Song6Peng-Peng Zhang7Lei Chen8College of Life Sciences, Xinyang Normal University, Xinyang, ChinaInstitute for Conservation and Utilization of Agro-bioresources in Dabie Mountains, Xinyang Normal University, Xinyang, ChinaHenan Key Laboratory of Tea Biology, Xinyang Normal University, Xinyang, ChinaCollege of Life Sciences, Xinyang Normal University, Xinyang, ChinaInstitute for Conservation and Utilization of Agro-bioresources in Dabie Mountains, Xinyang Normal University, Xinyang, ChinaHenan Key Laboratory of Tea Biology, Xinyang Normal University, Xinyang, ChinaCollege of Life Sciences, Xinyang Normal University, Xinyang, ChinaCollege of Life Sciences, Xinyang Normal University, Xinyang, ChinaCollege of Life Sciences, Xinyang Normal University, Xinyang, ChinaDiabetes mellitus is considered as a risk factor of Alzheimer’s disease (AD), the front runner of neurodegenerative disorders. Streptozotocin (STZ) is a toxin for pancreatic β-cell, which can construct a model of insulin deficient diabetes through intraperitoneal or intravenous injection. A model generated by intracerebroventricular STZ (icv-STZ) also shows numerous aspects of sporadic AD. The protective roles of tea polyphenols epigallocatechin-3-gallate (EGCG) on both two diseases were researched by some scientists. This review highlights the link between diabetes and AD and recent studies on STZ injection-induced models, and also discusses the protection of EGCG to clarify its treatment in STZ-induced diabetes and AD.http://journal.frontiersin.org/article/10.3389/fphar.2017.00834/fulldiabetesAlzheimer’s diseasestreptozotocinepigallocatechin-3-gallateprotection
spellingShingle Jin-Jing Jia
Jin-Jing Jia
Jin-Jing Jia
Xian-Si Zeng
Xian-Si Zeng
Xian-Si Zeng
Xin-Qiang Song
Peng-Peng Zhang
Lei Chen
Diabetes Mellitus and Alzheimer’s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models
Frontiers in Pharmacology
diabetes
Alzheimer’s disease
streptozotocin
epigallocatechin-3-gallate
protection
title Diabetes Mellitus and Alzheimer’s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models
title_full Diabetes Mellitus and Alzheimer’s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models
title_fullStr Diabetes Mellitus and Alzheimer’s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models
title_full_unstemmed Diabetes Mellitus and Alzheimer’s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models
title_short Diabetes Mellitus and Alzheimer’s Disease: The Protection of Epigallocatechin-3-gallate in Streptozotocin Injection-Induced Models
title_sort diabetes mellitus and alzheimer s disease the protection of epigallocatechin 3 gallate in streptozotocin injection induced models
topic diabetes
Alzheimer’s disease
streptozotocin
epigallocatechin-3-gallate
protection
url http://journal.frontiersin.org/article/10.3389/fphar.2017.00834/full
work_keys_str_mv AT jinjingjia diabetesmellitusandalzheimersdiseasetheprotectionofepigallocatechin3gallateinstreptozotocininjectioninducedmodels
AT jinjingjia diabetesmellitusandalzheimersdiseasetheprotectionofepigallocatechin3gallateinstreptozotocininjectioninducedmodels
AT jinjingjia diabetesmellitusandalzheimersdiseasetheprotectionofepigallocatechin3gallateinstreptozotocininjectioninducedmodels
AT xiansizeng diabetesmellitusandalzheimersdiseasetheprotectionofepigallocatechin3gallateinstreptozotocininjectioninducedmodels
AT xiansizeng diabetesmellitusandalzheimersdiseasetheprotectionofepigallocatechin3gallateinstreptozotocininjectioninducedmodels
AT xiansizeng diabetesmellitusandalzheimersdiseasetheprotectionofepigallocatechin3gallateinstreptozotocininjectioninducedmodels
AT xinqiangsong diabetesmellitusandalzheimersdiseasetheprotectionofepigallocatechin3gallateinstreptozotocininjectioninducedmodels
AT pengpengzhang diabetesmellitusandalzheimersdiseasetheprotectionofepigallocatechin3gallateinstreptozotocininjectioninducedmodels
AT leichen diabetesmellitusandalzheimersdiseasetheprotectionofepigallocatechin3gallateinstreptozotocininjectioninducedmodels